| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/2006 | CA2594629A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | CA2594474A1 Pharmaceutical compounds |
| 07/27/2006 | CA2594423A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | CA2593520A1 Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 07/27/2006 | CA2593112A1 Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
| 07/27/2006 | CA2593038A1 Methods for treating adhesive capsulitis |
| 07/27/2006 | CA2592500A1 Methods of increasing cerebral blood flow |
| 07/27/2006 | CA2591914A1 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use |
| 07/27/2006 | CA2567446A1 Alphavirus vectors for respiratory pathogen vaccines |
| 07/27/2006 | CA2564112A1 Dalbavancin compositions for treatment of bacterial infections |
| 07/27/2006 | CA2563823A1 Beta-peptides |
| 07/26/2006 | EP1683866A2 Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1683809A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/26/2006 | EP1683807A1 Combination products for use in antitumoral treatment, comprising an antibody capable of inhibiting the activity of CSF-1 |
| 07/26/2006 | EP1683803A1 Water soluble prodrugs of hindered alcohols or phenols |
| 07/26/2006 | EP1683527A1 Method of inhibiting secretase activity |
| 07/26/2006 | EP1682664A2 Methods for the production of apolipoproteins in transgenic plants |
| 07/26/2006 | EP1682663A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682661A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 07/26/2006 | EP1682660A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/26/2006 | EP1682578A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 07/26/2006 | EP1682576A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/26/2006 | EP1682575A1 Igf-i responsive gene and use thereof |
| 07/26/2006 | EP1682574A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682573A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 07/26/2006 | EP1682571A1 A bidentate motif and methods of use |
| 07/26/2006 | EP1682570A1 A binding motif and methods of regulating cell function |
| 07/26/2006 | EP1682546A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | EP1682196A2 Medical implants and anti-scarring agents |
| 07/26/2006 | EP1682187A2 Oligoribonucleotides for the treatment of undesired skin and hair pigmentation due to rna interference |
| 07/26/2006 | EP1682184A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 07/26/2006 | EP1682180A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 07/26/2006 | EP1682178A2 Methods of therapy for cancers expressing the cd40 antigen |
| 07/26/2006 | EP1682174A2 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 07/26/2006 | EP1682171A2 Compositions and methods of treating neurological diseases |
| 07/26/2006 | EP1682169A1 Compositions and methods of treatment |
| 07/26/2006 | EP1682168A1 Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain |
| 07/26/2006 | EP1682167A1 Use of hyperpolymer haemoglobin for treating a pulmonary oedema |
| 07/26/2006 | EP1682166A1 Use of lh for generating libido and reaching orgasm in female subjects |
| 07/26/2006 | EP1682165A1 Use of interferon-tau in medicine |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682163A1 Proteins involved in quorum sensing |
| 07/26/2006 | EP1682159A1 Immunomodulating compositions and uses therefor |
| 07/26/2006 | EP1682106A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 07/26/2006 | EP1682091A1 Compositions of lipids and cationic peptides |
| 07/26/2006 | EP1682074A2 Compositions and methods for healthy pregnancy |
| 07/26/2006 | EP1682012A2 Composition and apparatus for transdermal delivery |
| 07/26/2006 | EP1501534B1 Desmopressin in an orodispersible dosage form |
| 07/26/2006 | EP1481065B1 Method for detection of leptin receptor ligands |
| 07/26/2006 | EP1465921B1 Corticotropin releasing factor receptor 2 agonists |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1387703B1 Fibrin material and method for producing and using the same |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351703B1 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 07/26/2006 | EP1349457B1 Liquid antimicrobial compositions |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1303294B1 Method for treating unstable angina pectoris |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1231933B1 An aqueous solution formulation of alpha-interferon |
| 07/26/2006 | EP1072273B1 Vascularization inhibitors |
| 07/26/2006 | EP1028743B1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGF-beta OR ACTIVIN |
| 07/26/2006 | EP1027069B1 Gene therapy for gaucher disease |
| 07/26/2006 | EP0985028B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 07/26/2006 | EP0934424B1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 07/26/2006 | EP0904100B1 Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules |
| 07/26/2006 | EP0866711B1 Montirelin for inhibiting sleep apnea |
| 07/26/2006 | EP0856058B1 Cell-cycle checkpoint genes |
| 07/26/2006 | EP0832222B1 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 07/26/2006 | CN1809750A Acetyl-coenzyme A carboxylase 2 as a target in the regulation of fat and insulin action |
| 07/26/2006 | CN1809632A Perivascular mesenchymal precursor cells |
| 07/26/2006 | CN1809590A Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/26/2006 | CN1809589A GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 07/26/2006 | CN1809587A Materials and methods relating to g-protein coupled receptor oligomers |
| 07/26/2006 | CN1809586A Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 07/26/2006 | CN1809378A Methods for inhibiting viral replication in vivo |
| 07/26/2006 | CN1809377A Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 07/26/2006 | CN1809376A Liquid stabilized protein formulations in coated pharmaceutical containers |
| 07/26/2006 | CN1809375A Apoptosis inducing agent and method of inducing apoptosis |
| 07/26/2006 | CN1809374A Proton-sensing G-protein coupled receptors and DNA sequences thereof |
| 07/26/2006 | CN1809373A Synthetic peptide combinations and methods of producing same |
| 07/26/2006 | CN1809372A Melanocortin recptor 4(MC4) agonists and their uses |
| 07/26/2006 | CN1809371A Lyase treatment for p. carinii |
| 07/26/2006 | CN1809370A Use of B7-H3 as an immunoregulatory agent |
| 07/26/2006 | CN1809345A Enalapril-nitroxyderivatives derivatives and related compounds as ACE inhibitors for the treatment of cardiovascular diseases |
| 07/26/2006 | CN1809343A Fast dissolving orally consumable films containing a sucralose as a sweetener |
| 07/26/2006 | CN1809287A Composition and foods for lowering glycemic index |
| 07/26/2006 | CN1809282A Methods for prevention hyperthyroidism in a cat and composition comprising limited iodine |
| 07/26/2006 | CN1809277A Tolerance to graft prior to thymic regeneration |
| 07/26/2006 | CN1807622A Gene coding alpha-conch toxin peptide and its uses |
| 07/26/2006 | CN1807612A Trypsin chymo-trypsin preparation method |
| 07/26/2006 | CN1807603A Low pyrogen staphylokinase and its preparation method |
| 07/26/2006 | CN1807454A GIBC gene and its coded protein and uses |
| 07/26/2006 | CN1807452A Helicobacter Pylori urease B subunit Th epitope peptide, its coding DNA, vaccine and uses |
| 07/26/2006 | CN1807450A SIP gene and its coded protein and uses |
| 07/26/2006 | CN1807449A BIM apoptosis effect minimum core sequence and its preparation and uses |
| 07/26/2006 | CN1806849A Method of treating tumors |